NRIX vs REG · rev $54.5M vs P/E 34, $12.93B cap
Nurix Therapeutics Inc (NRIX) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
REG does not have a complete income-statement cache yet.
NRIX currently screens at market cap $1.77B. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the NRIX and REG stock pages for the full models.
Not investment advice.